Table 2.

The 22 sequencedEnterococcus faeciumgenomes

Strain	ST	CC17	Country	Year	Source	Reference
1,231,408a	582	Yes	NAb	NA	Blood Culture of Hospitalized Patient	[38]
1,231,501	52	No	NA	NA	Blood Culture of Hospitalized Patient	[38]
Com15	583	No	USA (MA)	2006	Healthy Volunteer Feces	[38]
1,141,733	327	No	NA	NA	Blood Culture of Hospitalized Patient	[38]
1,230,933	18	Yes	NA	NA	Wound Swab of Hospitalized Patient	[38]
1,231,410	17	Yes	NA	NA	Skin and Soft Tissue Infection	[38]
1,231,502	203	Yes	NA	NA	Blood Culture of Hospitalized Patient	[38]
Com12	107	No	USA (MA)	2006	Healthy Volunteer Feces	[38]
E1039	42	No	Netherlands	1998	Healthy Volunteer Feces	[32]
E1162	17	Yes	France	1997	Blood Culture of Hospitalized Patient	[32]
E1071	32	No	Netherlands	2000	Hospitalized Patient Feces	[32]
E1679	114	No	Brazil	1998	Swab of Vascular Catheter	[32]
E1636	106	No	Netherlands	1961	Blood Culture of Hospitalized Patient	[32]
E980	94	No	Netherlands	1998	Healthy Volunteer Feces	[32]
U0317	78	Yes	Netherlands	2005	UTI of Hospitalized Patient	[32]
D344SRFc	21	No	France	1985	Clinical (Site not specified)	[42]
TC6	21	No	USA (OH)	NA	Transconjugant of C68 and D344SRF	[29]
C68	16	Yes	USA (OH)	1998	Endocarditis Patient (Feces)	[9]
TX0133	17	Yes	USA (TX)	2006	Endocarditis Patient (Blood)	This study
TX82	17	Yes	USA (TX)	1999	Endocarditis Patient (Blood)	[25]
TX16	18	Yes	USA (TX)	1992	Endocarditis Patient (Blood)	[43]
TX1330	107	No	USA (TX)	1994	Healthy Volunteer Feces	[17]

^aHybrid genome with ~1/3 of the core genes from the CA clade and 2/3 from the HA clade.

^bIndicates this information was not available.

^cA rifampin- and fusidic acid-resistant derivative of clinical strain E. faecium D344S in which the spontaneous loss of pbp5 and its surrounding region resulted in an ampicillin-susceptible phenotype.